Evaluation of the international index in the prognosis of high grade gastric MALT lymphoma

被引:12
作者
Castrillo, JM
Montalban, C
Abraira, V
Carrion, R
Cruz, MA
Larana, JG
Menarguez, J
Bellas, C
Piris, MA
GomezMarcos, F
Serrano, M
Rivas, C
机构
[1] Department of Internal Medicine, Fondación Jimenez Díaz, Universidad Autónoma, Madrid
[2] Department of Pathology, Fondación Jimenez Díaz, Universidad Autónoma, Madrid
[3] Department of Internal Medicine, Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[4] Department of Oncology, Hospital Gregorio Marañon, Universidad Complutense, Madrid
[5] Department of Pathology, Hospital Gregorio Marañon, Universidad Complutense, Madrid
[6] Department of Hematology, Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[7] Department of Oncology, Hospital Virgen de la Salud, Toledo
[8] Department of Pathology, Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[9] Clin. Epidemiol. and Biostatist. U., Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[10] Servicio de Medicina Interna, Fundación Jimenez Díaz, Madrid 28040
关键词
gastric lymphoma; high-grade lymphoma; international index; lymphoma; MALT lymphoma;
D O I
10.3109/10428199609045724
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The International Prognostic Index identifies four risk groups with different survival rates in aggressive non-Hodgkin's lymphoma. We have studied whether a slight modification of this index has prognostic significance in high grade gastric B-cell MALT lymphoma. In 53 patients with high grade gastric B-cell MALT lymphoma the following survival factors were investigated: age over or under 60 years, sex, B symptoms, more than one extranodal site of involvement other than the stomach, serum LDH levels, performance status, stage I/IIE1/IIE2 v.s. stage III/IV, treatment with surgery, chemotherapy or both modalities together and the four risk groups as defined by the Modified International Prognostic Index (MIPI). A multivariate Cox's test was used to evaluate the independent prognostic significance on survival of all the above variables. Advanced stage (III/IV) and involvement of more than one extranodal site not including stomach were the only variables influencing survival. The MIPI was not sufficient to separate groups with significant differences in survival or to stratify prognostic groups. In this series, the MIPI did not show prognostic significance in high grade gastric B-cell MALT lymphoma.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 11 条
[1]  
ABRAIRA V, 1984, PRESTA PAQUETE PROCE, P101
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]   COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].
FISHER, RI ;
GAYNOR, ER ;
DAHLBERG, S ;
OKEN, MM ;
GROGAN, TM ;
MIZE, EM ;
GLICK, JH ;
COLTMAN, CA ;
MILLER, TP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006
[4]  
ISAACSON PG, 1988, LANCET, V2, P1148
[5]   MALIGNANT-LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE [J].
ISAACSON, PG ;
SPENCER, J .
HISTOPATHOLOGY, 1987, 11 (05) :445-462
[6]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[7]   GASTRIC B-CELL MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) LYMPHOMA - CLINICOPATHOLOGICAL STUDY AND EVALUATION OF THE PROGNOSTIC FACTORS IN 143 PATIENTS [J].
MONTALBAN, C ;
CASTRILLO, JM ;
ABRAIRA, V ;
SERRANO, M ;
BELLAS, C ;
PIRIS, MA ;
CARRION, R ;
CRUZ, MA ;
LARANA, JG ;
MENARGUEZ, J ;
GOMEZMARCOS, F ;
RIVAS, C .
ANNALS OF ONCOLOGY, 1995, 6 (04) :355-362
[8]  
MUSSHOFF K, 1977, STRAHLENTHER ONKOL, V153, P218
[9]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39
[10]   AGGRESSIVE PRIMARY GASTROINTESTINAL LYMPHOMAS - REVIEW OF 91 PATIENTS TREATED WITH THE LNH-84 REGIMEN - A STUDY OF THE GROUPE-DETUDE-DES-LYMPHOMES-AGRESSIFS [J].
SALLES, G ;
HERBRECHT, R ;
TILLY, H ;
BERGER, F ;
BROUSSE, N ;
GISSELBRECHT, C ;
COIFFIER, B .
AMERICAN JOURNAL OF MEDICINE, 1991, 90 (01) :77-84